The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment

Yingli Guo1, Yajuan Xie2, Yao Luo1

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China.

Frontiers in Immunology
|February 28, 2022
PubMed

Insights

Long non-coding RNAs (lncRNAs) play a crucial role in the tumor immune microenvironment, influencing cancer progression and immunotherapy effectiveness. Targeting lncRNAs offers promising strategies for cancer diagnosis and treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumorigenesis involves genetic and epigenetic changes, with the immune system significantly impacting cancer development and spread.
  • Current cancer immunotherapies show limited efficacy in a majority of patients.
  • Long non-coding RNAs (lncRNAs) are key regulators in cancer and immunology, with emerging roles in immunotherapy.

Purpose of the Study:

  • To review the latest research on lncRNA functions within the tumor immune microenvironment.
  • To elucidate the mechanisms by which lncRNAs influence cancer progression and immune responses.
  • To discuss strategies for targeting lncRNAs in cancer therapy.

Main Methods:

  • Literature review of recent studies on lncRNAs and cancer immunotherapy.
  • Analysis of lncRNA involvement in key biological processes like immune cell function and tumor invasion.
  • Examination of current therapeutic strategies targeting lncRNAs.

Main Results:

  • LncRNAs regulate critical processes including neutrophil recruitment, macrophage polarization, NK cell cytotoxicity, and T cell function.
  • LncRNAs impact tumorigenesis, invasion, epithelial-mesenchymal transition (EMT), and angiogenesis.
  • LncRNAs are implicated in modulating the tumor immune microenvironment.

Conclusions:

  • LncRNAs are vital regulators in the tumor immune microenvironment, affecting various aspects of cancer biology.
  • Targeting lncRNAs presents a promising avenue for developing novel cancer biomarkers and therapeutics.
  • Further research into lncRNA mechanisms can advance cancer diagnosis and treatment strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
708
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.7K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K